Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor
Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...
GlucoTrack prices offering of 2.6M shares of common stock at $1.15
Glucotrack (GCTK) announced the pricing of a “best efforts” public offering of approximately 2.6M shares of common stock. The offering price of ...
Yahoo Finance5d
GlucoTrack, Inc. (GCTK)
The study met its primary endpoint with no procedure or device related serious adverse events reportedRUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK ...
GlucoTrack announces completion of first in human clinical study of CGM
Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous ...
Yahoo Finance4d
GlucoTrack, Inc. (GCTK)
Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and ...
Glucotrack, Inc. Announces Pricing Of $3.0 Million Public Offering
About Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing ...
Glucotrack, Inc.: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and ...
The Globe and Mail9d
Glucotrack Announces Reverse Stock Split
RUTHERFORD, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the ...
Glucotrack, Inc. Announces 1-for-20 Reverse Stock Split
Glucotrack, Inc. (Nasdaq: GCTK) disclosed a significant move within its capital structure. This Delaware corporation specializing in medical devices made public a press release involving a 1-for-20 ...